ProfileGDS4284 / 241696_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 49% 33% 5% 44% 42% 9% 45% 41% 74% 49% 36% 39% 21% 1% 55% 45% 26% 54% 61% 50% 46% 58% 46% 32% 8% 1% 34% 60% 16% 50% 64% 55% 60% 31% 41% 66% 42% 25% 54% 44% 65% 56% 41% 65% 58% 2% 31% 35% 63% 41% 58% 7% 12% 51% 7% 59% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control195.08549
GSM687648Patient 402 control89.266833
GSM687653Patient 403 control9.112595
GSM687658Patient 404 control160.11944
GSM687663Patient 411 control154.60142
GSM687668Patient 422 control15.50239
GSM687673Patient 424 control176.6245
GSM687678Patient 425 control146.4241
GSM687683Patient 427 control1025.5774
GSM687688Patient 428 control203.50449
GSM687695Patient 441 control171.77636
GSM687699Patient 443 control151.66439
GSM687704Patient 444 control42.001521
GSM687707Patient 448 control3.939971
GSM687712Patient 449 control293.32855
GSM687719Patient 450 control204.05945
GSM687724Patient 451 control72.238926
GSM687728Patient 452 control290.93554
GSM687646Patient 401 treated 24h441.80161
GSM687649Patient 402 treated 24h200.48650
GSM687665Patient 411 treated 24h194.16146
GSM687651Patient 402 treated 4 weeks363.17458
GSM687667Patient 411 treated 4 weeks183.48746
GSM687670Patient 422 treated 24h95.172532
GSM687671Patient 422 treated 4 weeks13.3688
GSM687654Patient 403 treated 24h2.490321
GSM687675Patient 424 treated 24h108.19934
GSM687685Patient 427 treated 24h391.63460
GSM687656Patient 403 treated 4 weeks25.267316
GSM687677Patient 424 treated 4 weeks213.79750
GSM687687Patient 427 treated 4 weeks524.07764
GSM687692Patient 428 treated 4h286.23955
GSM687716Patient 449 treated 4h380.44660
GSM687722Patient 450 treated 4h98.622831
GSM687680Patient 425 treated 24h142.2841
GSM687690Patient 428 treated 24h541.12966
GSM687700Patient 443 treated 24h213.29242
GSM687705Patient 444 treated 24h55.191925
GSM687714Patient 449 treated 24h259.71854
GSM687721Patient 450 treated 24h194.55844
GSM687682Patient 425 treated 4 weeks514.34865
GSM687694Patient 428 treated 4 weeks303.40856
GSM687702Patient 443 treated 4 weeks153.5341
GSM687718Patient 449 treated 4 weeks530.8565
GSM687723Patient 450 treated 4 weeks368.27158
GSM687661Patient 404 treated 4h6.045682
GSM687710Patient 448 treated 4h85.479231
GSM687726Patient 451 treated 4h120.10935
GSM687730Patient 452 treated 4h651.16263
GSM687660Patient 404 treated 24h175.70841
GSM687697Patient 441 treated 24h412.90458
GSM687709Patient 448 treated 24h13.38477
GSM687725Patient 451 treated 24h27.32112
GSM687729Patient 452 treated 24h294.98451
GSM687727Patient 451 treated 4 weeks16.26227
GSM687731Patient 452 treated 4 weeks390.59959